Abstract
Oncolytic (replicating) adenovirus (Ad) vectors are emerging as a promising form of a cancer therapy agent. There has been a need for an appropriate animal model to study oncolytic Ad since human Ad replication is usually species specific. We have shown that Syrian (golden) hamsters are an appropriate animal model to study human Ad5-based vectors. Syrian hamsters are immunocompetent, and they allow human Ad5 replication in normal tissues as well as in Syrian hamster cancer cells. The development of the Syrian hamster as a model to study oncolytic Ad vectors has opened avenues to explore the role of host immune response and preexisting immunity in Ad vector efficacy and toxicity/biodistribution following Ad vector administration. Since most of the normal tissues in the Syrian hamster are permissive for human Ad5 replication, Ad vectors can be studied in the context of orthotopic cancer model developed in Syrian hamsters.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Thomas, M. A., Spencer, J. F., La Regina, M. C., Dhar, D., Tollefson, A. E., Toth, K., et al. (2006) Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors. Cancer Res. 66, 1270–6
Dhar, D., Spencer, J. F., Toth, K., and Wold, W. S. (2009) Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters. J. Virol. 83, 2130–9
Dhar, D., Spencer, J. F., Toth, K., and Wold, W. S. (2009) Pre-existing Immunity and Passive Immunity to Adenovirus 5 Prevents Toxicity Caused by an Oncolytic Adenovirus Vector in the Syrian Hamster Model. Mol. Ther. 17, 1724–32
Lichtenstein, D. L., Spencer, J. F., Doronin, K., Patra, D., Meyer, J. M., Shashkova, E. V., et al. (2009) An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector. Cancer Gene Ther. 16, 644–54
Ying, B., Toth, K., Spencer, J. F., Meyer, J., Tollefson, A. E., Patra, D., et al. (2009) INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies. Cancer Gene Ther. 16, 625–37
Spencer, J. F., Sagartz, J. E., Wold, W. S. M., and Toth, K. (2009) New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster. Cancer Gene Ther. 16, 912–22
Thomas, M. A., Spencer, J. F., Toth, K., Sagartz, J. E., Phillips, N. J., and Wold, W. S. (2008) Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model. Mol. Ther. 16, 1665–73
Toth, K., Spencer, J. F., Dhar, D., Sagartz, J. E., Buller, R. M., Painter, G. R., et al. (2008) Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. Proc. Natl. Acad. Sci.USA 105, 7293–7
Bortolanza, S., Alzuguren, P., Bunuales, M., Qian, C., Prieto, J., and Hernandez-Alcoceba, R. (2007) Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamsters. Hum. Gene Ther. 18, 681–90
Bortolanza, S., Bunuales, M., Otano, I., Gonzalez-Aseguinolaza, G., Ortiz-de-Solorzano, C., Perez, D., et al. (2009) Treatment of pancreatic cancer with an oncolytic adenovirus expressing interleukin-12 in Syrian hamsters. Mol. Ther. 17, 614–22
Bortolanza, S., Bunuales, M., Alzuguren, P., Lamas, O., Aldabe, R., Prieto, J., et al. (2009) Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters. Cancer Gene Ther. 16, 703–12
Matthews, K., Noker, P. E., Tian, B., Grimes, S. D., Fulton, R., Schweikart, K., et al. (2009) Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer. Clin. Cancer Res. 15, 4131–7
Thomas, M. A., Spencer, J. F., and Wold, W. S. (2007) Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors. Methods Mol. Med. 130, 169–83
Tollefson, A. E., Kuppuswamy, M., Shashkova, E. V., Doronin, K., and Wold, W. S. (2007) Preparation and titration of CsCl-banded adenovirus stocks. Methods Mol. Med. 130, 223–35
Tollefson, A. E., Hermiston, T. W., and Wold, W. S. M. (1998) Preparation and titration of CsCl-banded adenovirus stocks. 21, 1–9
Acknowledgments
We thank Jacqueline Spencer, Maria Thomas, and other members of our laboratory for outstanding research and discussions. This research was supported by grant R01 CA118022 from the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Dhar, D., Toth, K., Wold, W.S.M. (2012). Syrian Hamster Tumor Model to Study Oncolytic Ad5-Based Vectors. In: Kirn, D., Liu, TC., Thorne, S. (eds) Oncolytic Viruses. Methods in Molecular Biology, vol 797. Humana, Totowa, NJ. https://doi.org/10.1007/978-1-61779-340-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-61779-340-0_4
Published:
Publisher Name: Humana, Totowa, NJ
Print ISBN: 978-1-61779-339-4
Online ISBN: 978-1-61779-340-0
eBook Packages: Springer Protocols